Concepedia

Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study

Mario Castro, Sally E. Wenzel, Eugene R. Bleecker, Emílio Pizzichini, Piotr Kuna, William W. Busse, David Gossage, Christine K. Ward, Yanping Wu, Bing Wang,

The Lancet Respiratory Medicine · 2014 · 484 citations · 26 references

DOI

Concepts

References

26

GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION

Romain Pauwels · Arerugī/Arerugi · 1996 · 10.1K citations

, , +10

Development and validation of a questionnaire to measure asthma control

Elizabeth F. Juniper, Paul M. O’Byrne, Gordon Guyatt et al. · European Respiratory Journal · 1999 · 2.5K citations · Full text

, , +8

Guidelines for Methacholine and Exercise Challenge Testing—1999: T <scp>his Official Statement of the American Thoracic Society Was Adopted by the ATS Board of Directors, July</scp> 1999

Robert O. Crapo, Richard Casaburi, Allan L. Coates et al. · American Journal of Respiratory and Critical Care Medicine · 2000 · 2.5K citations

, , +12

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

Ian Pavord, Stephanie Korn, Peter Howarth et al. · The Lancet · 2012 · 2.2K citations

, , +14

An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations

Helen K. Reddel, D. Robin Taylor, Eric D. Bateman et al. · American Journal of Respiratory and Critical Care Medicine · 2009 · 1.9K citations

, , +12